Cuprina (Cayman) (CUPR) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cuprina (Cayman) is the larger company by market cap ($11.8 million vs $11.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CUPR | RGNT |
|---|---|---|
| Share price | $1.69 | $1.60 |
| Market cap | $11.84M | $11.24M |
| 1-day change | -11.05% | -5.88% |
| YTD return | -40.63% | -74.78% |
| 1-year return | -78.79% | — |
| EPS (TTM) | $-1.40 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.80 | $15.50 |
| 52-week low | $1.45 | $1.23 |
| Distance from 52-week high | -88.58% | -89.68% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +525.00% |
| Average volume | 94.31K | 76.78K |
| Shares outstanding | 5.24M | 7.02M |
| Employees | 10 | — |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cuprina (Cayman)
CUPR stock →Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
Health Care · Industrial Specialties · 10 employees
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Health Care · Industrial Specialties
CUPR vs RGNT FAQ
Which is bigger, Cuprina (Cayman) or Regentis Biomaterials?
Cuprina (Cayman) (CUPR) is larger, with a market capitalization of $11.84M compared with $11.24M for Regentis Biomaterials (RGNT).
Are Cuprina (Cayman) and Regentis Biomaterials in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.